HK1129390A1 - Tropane compounds - Google Patents
Tropane compoundsInfo
- Publication number
- HK1129390A1 HK1129390A1 HK09109388.2A HK09109388A HK1129390A1 HK 1129390 A1 HK1129390 A1 HK 1129390A1 HK 09109388 A HK09109388 A HK 09109388A HK 1129390 A1 HK1129390 A1 HK 1129390A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tropane compounds
- tropane
- compounds
- formula
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68707P | 2007-10-25 | 2007-10-25 | |
PCT/US2008/012221 WO2009055077A1 (fr) | 2007-10-25 | 2008-10-27 | Composés de tropane |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1129390A1 true HK1129390A1 (en) | 2009-11-27 |
Family
ID=40287869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09109388.2A HK1129390A1 (en) | 2007-10-25 | 2009-10-09 | Tropane compounds |
Country Status (27)
Country | Link |
---|---|
US (1) | US8012956B2 (fr) |
EP (1) | EP2074120B1 (fr) |
JP (2) | JP5476307B2 (fr) |
KR (1) | KR101578792B1 (fr) |
CN (1) | CN101910168B (fr) |
AT (1) | ATE459622T1 (fr) |
AU (1) | AU2008317262B2 (fr) |
BR (1) | BRPI0818893B8 (fr) |
CA (1) | CA2703477C (fr) |
CO (1) | CO6321232A2 (fr) |
CY (1) | CY1110648T1 (fr) |
DE (1) | DE602008000754D1 (fr) |
DK (1) | DK2074120T3 (fr) |
EA (1) | EA018999B1 (fr) |
ES (1) | ES2342348T3 (fr) |
HK (1) | HK1129390A1 (fr) |
HR (1) | HRP20100292T1 (fr) |
IL (1) | IL205202A0 (fr) |
MX (1) | MX2010004493A (fr) |
NZ (1) | NZ585137A (fr) |
PL (1) | PL2074120T3 (fr) |
PT (1) | PT2074120E (fr) |
RS (1) | RS51346B (fr) |
SG (1) | SG2012079653A (fr) |
SI (1) | SI2074120T1 (fr) |
WO (1) | WO2009055077A1 (fr) |
ZA (1) | ZA201002987B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2707047C (fr) * | 2007-12-12 | 2017-11-28 | Rigel Pharmaceuticals, Inc. | Composes de carboxamide, de sulfonamide et d'amine servant a traiter les troubles metaboliques |
FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
UY32940A (es) | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
US9145425B2 (en) | 2010-04-05 | 2015-09-29 | Shionogi & Co., Ltd. | Cephem compound having catechol group |
US20140080810A1 (en) | 2010-11-15 | 2014-03-20 | Exelixis, Inc. | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture |
EP2740474A1 (fr) | 2012-12-05 | 2014-06-11 | Instituto Europeo di Oncologia S.r.l. | Dérivés de cyclopropylamine utiles comme inhibiteurs d'histone-déméthylases kdm1a |
US20150352086A1 (en) * | 2013-01-07 | 2015-12-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Heat shock protein (hsp) inhibition and monitoring effectiveness thereof |
JP6485817B2 (ja) | 2013-08-21 | 2019-03-20 | ヤンセン バイオファーマ インク. | 抗ウイルス化合物 |
WO2015074025A1 (fr) * | 2013-11-18 | 2015-05-21 | Del Mar Pharmaceuticals | Analyse par clhp des impuretés contenues dans du dianhydrogalactitol |
WO2015181380A1 (fr) | 2014-05-30 | 2015-12-03 | Ieo - Istituto Europeo Di Oncologia S.R.L. | Composés de cyclopropylamine à utiliser en tant qu'inhibiteurs de l'histone déméthylase |
EP2949648A1 (fr) | 2014-05-30 | 2015-12-02 | IEO - Istituto Europeo di Oncologia Srl | Dérivés de cyclopropylamine en tant qu'inhibiteurs de l'histone déméthylase |
TW201625243A (zh) | 2014-10-14 | 2016-07-16 | 艾克塞里克斯公司 | 用於治療黑素瘤之藥物組合 |
JP2018521131A (ja) * | 2015-07-16 | 2018-08-02 | アクル ファーマ エービー | 標識である細胞毒性基または免疫調節基へ連結したslc6a3リガンドを用いる腎細胞癌の検出および治療 |
EP3588064B1 (fr) * | 2017-02-23 | 2022-09-07 | IHI Corporation | Sonde de détection de radicaux oh, dispositif de mesure de radicaux oh et procédé de mesure de radicaux oh |
CN108164529B (zh) * | 2017-12-25 | 2020-04-24 | 三峡大学 | 一种小分子抑制剂sld9059及其在制药中的应用 |
MX2020007403A (es) | 2018-01-10 | 2020-11-11 | Allinky Biopharma | Compuestos de tetrahidroisoquinolina. |
CN111825702A (zh) * | 2019-04-22 | 2020-10-27 | 成都科岭源医药技术有限公司 | 一种氮杂*并吲唑类衍生物及其制备方法和用途 |
CN110698395B (zh) * | 2019-10-22 | 2021-05-25 | 杭州百诚医药科技股份有限公司 | 一种托吡司特的中间体的制备方法 |
CN112920078A (zh) * | 2019-12-05 | 2021-06-08 | 武汉珈汇精化科技有限公司 | 一种制备4-氰基苯甲酸甲酯的方法和一种制备4-氰基苯甲酸的方法 |
TW202136238A (zh) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | RORγt抑制劑及其製備方法和用途 |
AU2021362975A1 (en) * | 2020-10-14 | 2023-05-25 | Ranok Therapeutics (Hangzhou) Co. Ltd. | Methods and compositions for targeted protein degradation |
CN114591192A (zh) * | 2020-12-04 | 2022-06-07 | 江西仰立新材料有限公司 | 一种n-环丙甲基苯胺类化合物的制备方法 |
WO2022132679A1 (fr) * | 2020-12-18 | 2022-06-23 | Merck Sharp & Dohme Corp. | Composés pyrimidine amido-substitués et procédés d'utilisation associée pour traiter les virus herpétiques |
CN112707809B (zh) * | 2020-12-30 | 2023-08-29 | 丽珠集团新北江制药股份有限公司 | 一种制备噁唑啉杀虫剂氟雷拉纳中间体的方法 |
WO2023009330A1 (fr) * | 2021-07-26 | 2023-02-02 | Zoetis Services Llc | Composés inhibiteurs de la sérotonine 5-ht2b |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0101641A3 (fr) | 1982-07-22 | 1984-03-28 | Beecham Group Plc | Dérivés sulphonylamino-aza-bicycloalkyles |
FR2738569B1 (fr) | 1995-09-12 | 1997-11-28 | Pf Medicament | Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique |
NZ326354A (en) | 1996-01-15 | 1999-05-28 | Janssen Pharmaceutica Nv | 3-(substituted-1-piperazinyl)-6-(substituted-1,2,4-thiadiazol-5 -yl)-pyridazine derivatives and medicaments |
HUP0202001A2 (hu) * | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok |
ES2329133T3 (es) | 2003-05-28 | 2009-11-23 | Theravance, Inc. | Compuestos azabicicloalcanicos como antagonistas de receptores de muscarinicos. |
JP2009513491A (ja) * | 2003-06-24 | 2009-04-02 | ノイロサーチ アクティーゼルスカブ | 新規な8−アザ−ビシクロ[3.2.1]オクタン誘導体、及びモノアミン神経伝達物質の再取り込み阻害剤としてのその使用 |
GB0323236D0 (en) * | 2003-10-03 | 2003-11-05 | Pfizer Ltd | Chemical compounds |
JP4874107B2 (ja) * | 2003-10-03 | 2012-02-15 | ファイザー・インク | Hiv及び炎症の治療のためのccr5受容体拮抗活性を有するイミダゾピリジン置換トロパン誘導体 |
PL1731518T3 (pl) * | 2004-03-31 | 2014-11-28 | Nippon Soda Co | Cykliczny związek aminowy oraz środek zwalczający szkodniki |
FR2873693B1 (fr) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
EP1838705A2 (fr) | 2005-01-13 | 2007-10-03 | Neurosearch A/S | Nouveaux derives de 8-aza-bicyclo[3.2.1]octane et leur utilisation comme inhibiteurs du recaptage du neurotransmetteur monoamine |
EP2251341A1 (fr) * | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Hétérocycles inhibiteurs de Janus kinase-3 |
JP4871290B2 (ja) * | 2005-10-06 | 2012-02-08 | 日本曹達株式会社 | 架橋環状アミン化合物および有害生物防除剤 |
ES2382481T3 (es) * | 2006-09-01 | 2012-06-08 | Otsuka Agritechno Co., Ltd | Compuesto de N-piridilpiperidina, método para producir el mismo, y agente de control de plagas |
-
2008
- 2008-10-27 KR KR1020107011444A patent/KR101578792B1/ko not_active Application Discontinuation
- 2008-10-27 AT AT08832769T patent/ATE459622T1/de active
- 2008-10-27 PL PL08832769T patent/PL2074120T3/pl unknown
- 2008-10-27 JP JP2010531069A patent/JP5476307B2/ja active Active
- 2008-10-27 PT PT08832769T patent/PT2074120E/pt unknown
- 2008-10-27 CN CN200880122860.5A patent/CN101910168B/zh active Active
- 2008-10-27 AU AU2008317262A patent/AU2008317262B2/en active Active
- 2008-10-27 CA CA2703477A patent/CA2703477C/fr active Active
- 2008-10-27 EP EP08832769A patent/EP2074120B1/fr active Active
- 2008-10-27 RS RSP-2010/0220A patent/RS51346B/en unknown
- 2008-10-27 US US12/290,159 patent/US8012956B2/en active Active
- 2008-10-27 WO PCT/US2008/012221 patent/WO2009055077A1/fr active Application Filing
- 2008-10-27 ES ES08832769T patent/ES2342348T3/es active Active
- 2008-10-27 DK DK08832769.7T patent/DK2074120T3/da active
- 2008-10-27 SG SG2012079653A patent/SG2012079653A/en unknown
- 2008-10-27 BR BRPI0818893A patent/BRPI0818893B8/pt active IP Right Grant
- 2008-10-27 MX MX2010004493A patent/MX2010004493A/es active IP Right Grant
- 2008-10-27 DE DE602008000754T patent/DE602008000754D1/de active Active
- 2008-10-27 EA EA201070519A patent/EA018999B1/ru not_active IP Right Cessation
- 2008-10-27 NZ NZ585137A patent/NZ585137A/en unknown
- 2008-10-27 SI SI200830024T patent/SI2074120T1/sl unknown
-
2009
- 2009-10-09 HK HK09109388.2A patent/HK1129390A1/xx unknown
-
2010
- 2010-04-19 IL IL205202A patent/IL205202A0/en active IP Right Grant
- 2010-04-29 ZA ZA2010/02987A patent/ZA201002987B/en unknown
- 2010-05-24 HR HR20100292T patent/HRP20100292T1/hr unknown
- 2010-05-24 CO CO10061824A patent/CO6321232A2/es not_active Application Discontinuation
- 2010-06-01 CY CY20101100483T patent/CY1110648T1/el unknown
-
2013
- 2013-12-13 JP JP2013257559A patent/JP5745021B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201002987B (en) | Tropane compounds | |
PH12017501192A1 (en) | Certain amino-pyridazines, compositions thereof, and methods of their use | |
WO2010003133A3 (fr) | Modulateurs de cdk | |
UA107445C2 (uk) | 5-фторпіримідинові похідні як фунгіциди | |
MY193277A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
MY153921A (en) | Aminopyrazole derivatives | |
NZ597517A (en) | 5-fluoropyrimidinone derivatives | |
MY153915A (en) | Organic compounds | |
PH12012501905A1 (en) | Quinoline derivatives and their use as fungicides | |
MY170878A (en) | [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 | |
NZ603151A (en) | N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives | |
WO2007115821A3 (fr) | Composés organiques | |
MX2009011578A (es) | 6-fenilpirimidinonas como moduladores de pim. | |
MX2011008176A (es) | Derivados de 3,3'-espiroindolinona como agentes anticancerigenos. | |
MX2011012739A (es) | Derivados fluorados de aminotriazol. | |
IN2012DN00765A (fr) | ||
NZ597570A (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
NO20085317L (no) | Imidazoazepinonforbindelser | |
GB201305247D0 (en) | Amide Compounds | |
IN2014DN10669A (fr) | ||
GB201020397D0 (en) | Compounds | |
DE602008002598D1 (en) | Cyclohexylderivate | |
NZ590367A (en) | 9-Substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials | |
IL209732A0 (en) | Salicylamide derivatives as nicotinic alpha 7 modulators | |
UA27344U (en) | Use of pollentar pharmaceutical composition as cerebroprotective agent |